USD 0.01
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | -145.23 Thousand USD | 61.39% |
2023 | -376.14 Thousand USD | 13.36% |
2022 | -434.13 Thousand USD | -5090.09% |
2021 | 8700.00 USD | 0.0% |
2020 | - USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | -8723.00 USD | 45.27% |
2024 Q4 | -99.19 Thousand USD | -1037.11% |
2024 Q2 | -15.93 Thousand USD | 25.48% |
2024 Q1 | -21.39 Thousand USD | 51.61% |
2024 FY | -145.24 Thousand USD | 61.39% |
2023 Q2 | -5379.00 USD | 98.05% |
2023 FY | -376.14 Thousand USD | 13.36% |
2023 Q4 | -44.2 Thousand USD | 12.56% |
2023 Q3 | -50.55 Thousand USD | -839.82% |
2023 Q1 | -276 Thousand USD | -52.55% |
2022 FY | -434.13 Thousand USD | -5090.09% |
2022 Q1 | -90.08 Thousand USD | -1939.09% |
2022 Q3 | 4897.00 USD | 102.91% |
2022 Q2 | -168.02 Thousand USD | -86.51% |
2022 Q4 | -180.92 Thousand USD | -3794.61% |
2021 Q2 | -30.00 USD | 99.65% |
2021 FY | 8700.00 USD | 0.0% |
2021 Q4 | -4418.00 USD | -120.33% |
2021 Q3 | 21.72 Thousand USD | 72526.67% |
2021 Q1 | -8580.00 USD | 0.0% |
2020 FY | - USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
China Medicine Corporation | 12.26 Million USD | 101.184% |
Exlites Holdings International, Inc. | -15.49 Thousand USD | -837.631% |
Itonis, Inc. | -38.31 Thousand USD | -279.115% |
One Step Vending Corp. | -27.79 Thousand USD | -422.63% |
MediPal Holdings Corporation | 312.71 Million USD | 100.046% |
PD-Rx Pharmaceuticals, Inc. | -190.47 Thousand USD | 23.75% |
Pharmagen, Inc. | -2159.03 USD | -6627.049% |
Suzuken Co., Ltd. | 230.42 Million USD | 100.063% |